The FDA Goes Live with LifeSphere MultiVigilance, Modernizing Pharmacovigilance Capabilities with FAERS II
ArisGlobal’s industry leading pharmacovigilance platform automates the intake, triage, and ...
ArisGlobal’s “2021 State of the Industry Report” Explores Automation Adoption
Report reveals how life sciences companies currently use automation and ...
Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal’s LifeSphere® MultiVigilance to Advance Data Management from Clinical Trials
Innovative R&D company selects LifeSphere by ArisGlobal to further develop ...
LifeSphere Clinical Leader to Discuss Emerging Technology and Readiness at TMF Summit
ArisGlobal's LifeSphere clinical and regulatory product leader will host a ...
ArisGlobal to Discuss AI Enabled Data Fabric and Emerging Pharmacovigilance Technologies at World Drug Safety
The life sciences R&D technology leader will lead keynote sessions ...
ArisGlobal LifeSphere MultiVigilance is Selected By Asahi Kasei Pharma
Miami, Florida, Tokyo, August 23, 2021 Asahi Kasei Pharma Corp. ...
ArisGlobal’s LifeSphere IDMP Requirements, Readiness and Capabilities Acknowledged in Gens & Associates Report
ArisGlobal LifeSphere IDMP Requirements, Readiness and Capabilities Acknowledged in Gens ...
ArisGlobal Awarded Frost & Sullivan 2021 North America Customer Value Leadership
ArisGlobal recognized by Frost & Sullivan for enabling life sciences ...
ArisGlobal Highlights R&D Innovation, Digital Transformation, and AI at Breakthrough2021
Life sciences leader announces virtual conference to spotlight trends that ...
Xihua Scientific Selects LifeSphere MultiVigilance to Advance Pharmacovigilance Services
Fast-growing CRO uses the only automated, end-to-end safety system to ...
